Laurus Labs reports 54% fall in Q4 consolidated net profit

28 Apr 2023 Evaluate

Laurus Labs reported results for fourth quarter (Q4) and year ended March 31, 2023.

Laurus Labs has reported 53.77% fall in its net profit at Rs 102.28 crore for the quarter under review as compared to Rs 221.22 crore for the same quarter in the previous year. Total income of the company decreased by 6.86% at Rs 1,285.28 crore for Q4FY23 as compared to Rs 1,379.95 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 53.76% fall in its net profit at Rs 107.24 crore for fourth quarter ended March 31, 2023 as compared to Rs 231.90 crore for the same quarter in the previous year.  Total income of the company decreased by 3.05% at Rs 1,382.61 crore for Q4FY23 as compared to Rs 1,426.12 crore for the corresponding quarter previous year.

For the year ended March 31, 2023, the company has reported 1.37% rise in its net profit at Rs 760.38 crore as compared to Rs 750.09 crore for the previous year. Total income of the company increased by 22.43% at Rs 5,789.40 crore for year under review as compared to Rs 4,728.59 crore for year ended March 31, 2022.

For the year ended March 31, 2023, on the consolidated basis, the company has reported 4.30% fall in its net profit at Rs 796.64 crore as compared to Rs 832.43 crore for the previous year. However, total income of the company increased by 22.13% at Rs 6,046.55 crore for year under review as compared to Rs 4,950.87 crore for year ended March 31, 2022.

Laurus Labs Share Price

586.40 15.60 (2.73%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.